GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guardion Health Sciences Inc (STU:0QTA) » Definitions » EPS (Diluted)

Guardion Health Sciences (STU:0QTA) EPS (Diluted) : €0.11 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Guardion Health Sciences EPS (Diluted)?

Guardion Health Sciences's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was €0.30. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.11.

Guardion Health Sciences's EPS (Basic) for the three months ended in Dec. 2023 was €0.30. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.11.

Guardion Health Sciences's EPS without NRI for the three months ended in Dec. 2023 was €-0.29. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €-2.01.

During the past 3 years, the average EPS without NRIGrowth Rate was 54.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 50.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Guardion Health Sciences's highest 3-Year average EPS without NRI Growth Rate was 54.90% per year. The lowest was -6.40% per year. And the median was 32.60% per year.


Guardion Health Sciences EPS (Diluted) Historical Data

The historical data trend for Guardion Health Sciences's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardion Health Sciences EPS (Diluted) Chart

Guardion Health Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only -80.55 -24.66 -46.22 -13.36 0.11

Guardion Health Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.22 0.39 -0.86 0.27 0.30

Competitive Comparison of Guardion Health Sciences's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Guardion Health Sciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guardion Health Sciences's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guardion Health Sciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where Guardion Health Sciences's PE Ratio falls into.



Guardion Health Sciences EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Guardion Health Sciences's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0.145-0)/1.271
=0.11

Guardion Health Sciences's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0.39-0)/1.264
=0.31

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guardion Health Sciences  (STU:0QTA) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Guardion Health Sciences EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Guardion Health Sciences's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Guardion Health Sciences (STU:0QTA) Business Description

Traded in Other Exchanges
Address
2925 Richmond Avenue, Suite 1200, Houston, TX, USA, 77098
Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Medical Foods include Lumega-Z and GlaucoCetin; Medical Devices include Mapcat SF, VectorVision, CSV-1000 and CSV-2000; Nutraceuticals include ImmuneSF.

Guardion Health Sciences (STU:0QTA) Headlines

No Headlines